Related Experiment Videos
Novel biomarkers in heart failure: an overview
Jonathan R Dalzell1, Colette E Jackson, Theresa A McDonagh
1British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK. j.dalzell@nhs.net
Biomarkers in Medicine
|May 19, 2010
Summary
New biomarkers are emerging for heart failure, a complex syndrome impacting cardiac function. These markers aid in diagnosis, prognosis, and management by reflecting underlying biological pathways.
Area of Science:
- Cardiology
- Biochemistry
- Pathophysiology
Background:
- Heart failure is a complex systemic syndrome caused by impaired cardiac function.
- Numerous biological pathways, both detrimental and protective, are implicated in heart failure.
- Biomarkers derived from these pathways are crucial for clinical applications.
Purpose of the Study:
- To review recently identified biomarkers for heart failure.
- To discuss their role in diagnosis, prognostication, and management.
- To identify areas for future research in heart failure biomarkers.
Main Methods:
- Literature review of recent studies on heart failure biomarkers.
- Analysis of biological pathways involved in heart failure.
- Synthesis of current knowledge on candidate biomarkers.
Main Results:
- Several new biomarkers have been identified, reflecting various pathophysiological pathways.
- These biomarkers show potential for improving diagnosis and patient management.
- Understanding of heart failure pathophysiology is continuously advancing.
Conclusions:
- Recently identified biomarkers offer promising tools for heart failure management.
- Further research is needed to validate and implement these biomarkers.
- Continued investigation into heart failure pathophysiology will yield more diagnostic and prognostic markers.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:30Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...